07.03.12
Encap Drug Delivery has invested $2 million to expand capabilities at its Oakbank Park Way facility with additional high volume manufacturing equipment to support CMO services. The company has purchased product mixing and capsule filling equipment, including a highly flexible Esco Labor (EL200) mixer and a high speed Bosch filling machine (GKF2500L) and weight checker (KKE2500). Installation of the new equipment will be completed by February 2013.
Encap’s chief executive officer, Dr. Stephen Brown, said, “Encap has seen tremendous growth in its PDS business in the last two years with the initiation of more than 30 new client projects. We are seeing a growing interest in our commercial manufacturing capabilities and we have discussions progressing with a number of companies on their late stage Phase III products. Encap is investing to make sure that we have the best facilities and the most advanced manufacturing technology available to meet the needs of these new customers over the coming months and years. With the addition of this new equipment we are now capable of outputting over six million capsules per day.”
Encap’s chief executive officer, Dr. Stephen Brown, said, “Encap has seen tremendous growth in its PDS business in the last two years with the initiation of more than 30 new client projects. We are seeing a growing interest in our commercial manufacturing capabilities and we have discussions progressing with a number of companies on their late stage Phase III products. Encap is investing to make sure that we have the best facilities and the most advanced manufacturing technology available to meet the needs of these new customers over the coming months and years. With the addition of this new equipment we are now capable of outputting over six million capsules per day.”